Slides: Promise of epigenetic modulation as a target in atherosclerotic patientsAug. 26, 2017 - Barcelona, Spain - Erik SG Stroes, MD, AMC, Amsterdam, The Netherlands
The slides are prepared and presented by the speaker during a CME accredited symposium: Managing Diabetes & CVD: Is epigenetics a new way forward? held at ESC 2017 in Barcelona. The slides are an educational service to registered PACE members only. PACE is not responsible for the content, opinions expressed in the slides.
Erik Stroes, MD, is Internist Vascular Medicine, Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands
This symposium was supported by an unrestricted educational grant provided by Resverlogix